TickerFacts.

A business in context

NEUP research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-K · Annual report

    Report date 2026-06-30 · 0001193125-26-395536

  2. DEF 14A · Proxy statement

    Report date 2026-11-02 · 0001140361-26-037139

  3. 8-K · Current report

    Report date 2026-07-20 · 0001213900-26-081052 · Items 1.01,5.01,7.01,9.01

  4. 8-K · Current report

    Report date 2026-05-21 · 0001213900-26-061028 · Items 8.01

  5. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-225442

  6. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001193125-26-054509

  7. 4 · Ownership change

    Report date 2026-01-20 · 0001213900-26-006173

  8. 4 · Ownership change

    Report date 2026-01-20 · 0001213900-26-006172

  9. 4 · Ownership change

    Report date 2026-01-20 · 0001213900-26-006171

  10. 4 · Ownership change

    Report date 2026-01-20 · 0001213900-26-006170

  11. 8-K · Current report

    Report date 2025-12-31 · 0001213900-26-002245 · Items 1.01,1.02,9.01

  12. 8-K · Current report

    Report date 2025-12-18 · 0001213900-25-123289 · Items 3.01

  13. 8-K · Current report

    Report date 2025-12-12 · 0001213900-25-122777 · Items 5.07

  14. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-281579

  15. DEF 14A · Proxy statement

    Report date 2025-12-09 · 0001140361-25-039748

  16. 8-K · Current report

    Report date 2025-10-27 · 0001213900-25-102607 · Items 1.01,3.03,5.03,8.01,9.01

  17. 4 · Ownership change

    Report date 2025-10-21 · 0000902664-25-004536

  18. 8-K · Current report

    Report date 2025-10-20 · 0001213900-25-100371 · Items 8.01,9.01

  19. 10-K · Annual report

    Report date 2025-06-30 · 0001193125-25-223338

  20. 8-K · Current report

    Report date 2025-09-10 · 0001213900-25-087950 · Items 3.01,9.01

  21. 4 · Ownership change

    Report date 2025-08-27 · 0001213900-25-082904

  22. 8-K · Current report

    Report date 2025-07-18 · 0001213900-25-065723 · Items 3.01,9.01

  23. 8-K · Current report

    Report date 2025-05-20 · 0001213900-25-045970 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-075175

  25. 4/A · Ownership change

    Report date 2025-04-16 · 0001213900-25-045445

  26. 4 · Ownership change

    Report date 2025-04-16 · 0001213900-25-033144

  27. 10-Q · Quarterly report

    Report date 2024-12-31 · 0000950170-25-020473

  28. 8-K · Current report

    Report date 2025-01-10 · 0001213900-25-003492 · Items 8.01

  29. 8-K · Current report

    Report date 2024-12-23 · 0001213900-24-112016 · Items 1.01,3.01,3.02,3.03,5.01,5.02,5.03,5.05,8.01,9.01

  30. 8-K · Current report

    Report date 2024-12-16 · 0001213900-24-109347 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2024-12-11 · 0001213900-24-108436 · Items 5.07,9.01

  32. 8-K · Current report

    Report date 2024-11-18 · 0001213900-24-100971 · Items 1.01,9.01

  33. SC 13G · Ownership disclosure

    0001172661-24-005076

  34. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-127032

  35. SC 13G/A · Ownership disclosure

    0000902664-24-006517

  36. DEF 14A · Proxy statement

    Report date 2024-12-11 · 0001213900-24-096782

  37. 8-K · Current report

    Report date 2024-11-08 · 0001213900-24-095926 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2024-10-09 · 0001213900-24-086918 · Items 5.02

  39. SC 13D/A · Ownership disclosure

    0001193125-24-233941

  40. 8-K · Current report

    Report date 2024-10-01 · 0001213900-24-084175 · Items 1.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001191070Neuphoria Therapeutics Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • BIONOMICS LIMITED/FI · former SEC name · 2002-09-11 to 2024-12-23

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-06-30$15.65M$16.60M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗